We are live on ! Find out more
NTCM

Nine Ten Capital Management Portfolio holdings

AUM $315M
1-Year Est. Return 62.95%
This Fund
S&P 500
This Quarter Est. Return
-10.1%
1 Year Est. Return
+62.95%
3 Year Est. Return
+88.95%
5 Year Est. Return
+99.78%
10 Year Est. Return
+1,599.35%
AUM
$316M
AUM Growth
-$42.3M
Cap. Flow
-$1.61M
Cap. Flow %
-0.51%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
4
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
HSKA
Heska Corp
HSKA
+$19.1M
2
SNEX icon
StoneX
SNEX
+$4.4M
3
SIBN icon
SI-BONE Inc
SIBN
+$1.69M
4
IRMD icon
iRadimed
IRMD
+$471K
5
TRUP icon
Trupanion
TRUP
+$466K

Top Sells

Rank Stock Value
1
MLAB icon
Mesa Laboratories
MLAB
+$10.8M
2
INST
Instructure, Inc.
INST
+$9.64M
3
OFLX icon
Omega Flex
OFLX
+$6.66M
4
TTGT icon
TechTarget
TTGT
+$706K

Sector Composition

Rank Sector Weight
1 Financials 33.58%
2 Consumer Discretionary 18.77%
3 Healthcare 8.31%
4 Technology 6.11%
5 Industrials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
1
DELISTED
Instructure, Inc.
INST
$102M 32.43%
2,644,837
-236,551
-8% -$9.64M
TRUP icon
2
Trupanion
TRUP
$1.05B
$77.2M 24.43%
3,035,821
+15,907
+0.5% +$466K
WINA icon
3
Winmark
WINA
$1.19B
$59.3M 18.77%
336,077
SNEX icon
4
StoneX
SNEX
$8.83B
$28.9M 9.15%
3,563,236
+561,695
+19% +$4.4M
HSKA
5
DELISTED
Heska Corp
HSKA
$21.2M 6.7%
298,608
+254,842
+582% +$19.1M
TTGT icon
6
TechTarget
TTGT
$246M
$19.3M 6.11%
857,328
-30,741
-3% -$706K
SIBN icon
7
SI-BONE Inc
SIBN
$737M
$4.62M 1.46%
261,315
+88,050
+51% +$1.69M
OFLX icon
8
Omega Flex
OFLX
$298M
$2.51M 0.8%
24,564
-80,281
-77% -$6.66M
IRMD icon
9
iRadimed
IRMD
$1.21B
$485K 0.15%
+23,079
New +$471K
MLAB icon
10
Mesa Laboratories
MLAB
$539M
-44,019
Closed -$10.8M

Similar funds

Nine Ten Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Nine Ten Capital Management held 10 positions worth $316M, down 12% from $358M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Nine Ten Capital Management's Q3 2019 filing shows 1 new, 4 increased, 3 reduced and 1 closed positions. Its largest new stake was iRadimed: 23,079 shares worth $485K. The largest sale was Mesa Laboratories, an estimated $10.8M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Nine Ten Capital Management's largest Q3 2019 buy was iRadimed: 23,079 shares worth $485K.
  • Nine Ten Capital Management added most to Heska Corp in Q3 2019, an estimated $19.1M increase.
  • Nine Ten Capital Management's biggest Q3 2019 reduction was Instructure, Inc., cutting an estimated $9.64M.
  • Nine Ten Capital Management fully exited Mesa Laboratories in Q3 2019, selling an estimated $10.8M.
  • Nine Ten Capital Management's ten largest holdings make up 100% of its $316M portfolio in Q3 2019.
  • Nine Ten Capital Management opened 1 new position and closed 1 in Q3 2019.
  • Nine Ten Capital Management's portfolio value fell 12% quarter-over-quarter to $316M.

Based on Nine Ten Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.